SpiderRock Advisors’s Elevance Health ELV Stock Holding History

SpiderRock Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$208K	Hold	400	–	–	﹤0.01%	797
2024 Q2	$217K	Hold	400	–	–	﹤0.01%	732
2024 Q1	$205K	Buy	+400	New	+$199K	0.01%	692
2023 Q4	–	Hold	0	–	–	–	162
2023 Q3	–	Hold	0	–	–	–	149
2023 Q2	–	Hold	0	–	–	–	134
2023 Q1	–	Hold	0	–	–	–	127
2022 Q4	–	Hold	0	–	–	–	126
2022 Q3	–	Hold	0	–	–	–	128
2022 Q2	–	Hold	0	–	–	–	134
2022 Q1	–	Hold	0	–	–	–	130
2021 Q4	–	Hold	0	–	–	–	125
2021 Q3	–	Hold	0	–	–	–	114
2021 Q2	–	Hold	0	–	–	–	125
2021 Q1	–	Hold	0	–	–	–	134
2020 Q4	–	Hold	0	–	–	–	149
2020 Q3	–	Hold	0	–	–	–	148
2020 Q2	–	Hold	0	–	–	–	131
2020 Q1	–	Hold	0	–	–	–	121
2019 Q4	–	Hold	0	–	–	–	106

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SpiderRock Advisors's ELV Position: Q3 2024 in Review

SpiderRock Advisors increased its Elevance Health (ELV) stake by 25% in Q3 2024, buying an estimated $357K and bringing the position to 3,297 shares worth $1.71M. The position accounts for 0.03% of the portfolio, ranked #351.

SpiderRock Advisors first reported a position in ELV in Q1 2024 and has held it in 3 quarters since. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

SpiderRock Advisors held 3,297 shares of Elevance Health worth $1.71M as of Q3 2024.
SpiderRock Advisors bought 668 Elevance Health shares in Q3 2024, an estimated $357K.
Elevance Health made up 0.03% of SpiderRock Advisors's portfolio in Q3 2024, its #351 holding.
SpiderRock Advisors first reported a position in Elevance Health in Q1 2024 and has held it in 3 quarters since.
1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on SpiderRock Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.